Diamics, a Novato, Calif., maker of cancer diagnostics, raised $6 million by selling a 51 percent stake to Inverness Medical Innovations, a publicly traded diagnostic company.
Diamics is developing an improved system for taking Pap smears used in the early detection of cervical cancer. Inverness will assist in new-product design, manufacturing and distribution.